IMPACT OF CLINICAL FEATURES ON QUALITY OF LIFE IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
DOI:
https://doi.org/10.22159/ajpcr.2025v18i5.54424Keywords:
Polycystic Ovarian Syndrome, Quality of Life, Infertility, Menstrual Irregularities, Hyperandrogenism, PCOSQAbstract
Objectives: The primary objective of the study focuses on measuring the quality of life (QoL) in the study population using the polycystic ovarian syndrome questionnaire (PCOSQ). The secondary objective is to assess and correlate the impact of clinical features presented in affected women on QoL.
Methods: A prospective, cross-sectional study was conducted involving 354 patients diagnosed with the syndrome. Clinical symptoms, demographic features, and QoL indicators were noted and evaluated using patient case history and PCOSQ. Statistical analyses such as analysis of variance, the Kruskal–Wallis test, and multiple regression statistics were conducted to evaluate the effect of clinical factors on QoL domains.
Results: Five domains of health-related QoL (HRQoL) were assessed, signifying reduced QoL among the affected population. Hirsutism had the greatest impact on the study population (5.88±1.38). Emotional well-being was notably affected, with a moderate mean score of 4.34±1.30, influenced by hormonal imbalances and reproductive concerns that contributed to psychological distress. Weight issues (5.18±1.95) were positively correlated with acne severity (β=0.010, p<0.05), and menstrual distress (4.44±1.23) showed a negative association with body mass index (β=−0.018, p<0.05). Both weight concerns and menstrual irregularities contributed to reduced self-esteem and overall health of women. Evaluation of HRQoL across four phenotypes reported that phenotype A exhibited the poorest QoL across all the domains (p<0.05).
Conclusion: PCOS is a multifactorial disease that impairs the QoL in affected women. The study results emphasize the need for targeted management, therapeutic and non-pharmacological, for improving the patient’s overall well-being.
Downloads
References
Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: A systematic review and meta-analysis. Cureus. 2022;14(12):e32351. doi: 10.7759/ cureus.32351, PMID: 36628015
Skiba MA, Islam RM, Bell RJ, Davis SR. Understanding variation in prevalence estimates of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2018;24(6):694-709. doi: 10.1093/humupd/dmy022, PMID: 30059968
Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, et al. The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a community sample of Iranian population: Tehran lipid and glucose study. Front Endocrinol (Lausanne). 2022;13:825528. doi: 10.3389/fendo.2022.825528, PMID: 35299965
Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014;18(3):317-24. doi: 10.4103/2230-8210.131162, PMID: 24944925
Gupta M, Singh D, Toppo M, Priya A, Sethia S, Gupta P. A cross sectional study of polycystic ovarian syndrome among young women in Bhopal, central India. Int J Community Med Public Health. 2017;5(1):95-100. doi: 10.18203/2394-6040.ijcmph20175603
Gill H, Tiwari P, Dabadghao P. Prevalence of polycystic ovary syndrome in young women from North India: A community-based study. Indian J Endocrinol Metab. 2012;16(Suppl 2):S389-92. doi: 10.4103/2230- 8210.104104, PMID: 23565440
Ganie MA, Chowdhury S, Malhotra N, Sahay R, Bhattacharya PK, Agrawal S, et al. Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women. JAMA Netw Open. 2024;7(10):e2440583. doi: 10.1001/jamanetworkopen.2024.40583, PMID: 39441596
Deshpande PS, Gupta AS. Causes and prevalence of factors causing infertility in a public health facility. J Hum Reprod Sci. 2019 Oct- Dec;12(4):287-93. doi: 10.4103/jhrs.JHRS_140_18, PMID: 32038077
Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews. Clin Endocrinol (Oxf). 2018 Aug;89(6):683-99. doi: 10.1111/cen.13828, PMID: 30099747
Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820938305. doi: 10.1177/2042018820938305, PMID: 32670541
Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: Etiology, current management, and future therapeutics. J Clin Med. 2023 Feb 11;12(4):1454. doi: 10.3390/ jcm12041454, PMID: 36835989
Barthelmess EK, Naz RK. Polycystic ovary syndrome: Current status and future perspective. Front Biosci (Elite Ed). 2014;6(1):104-19. doi: 10.2741/e695, PMID: 24389146
Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007 Aug;22(8):2279-86. doi: 10.1093/ humrep/dem108, PMID: 17537782
Tabassum F, Jyoti C, Sinha HH, Dhar K, Akhtar MS. Impact of polycystic ovary syndrome on quality of life of women in correlation to age, basal metabolic index, education and marriage. PLoS One. 2021 Mar 10;16(3):e0247486. doi: 10.1371/journal.pone.0247486, PMID: 33690645
Vijayan SM, Kalaivani H, Mitra S, John J, Anila A, Damini BL, et al. Barriers to treatment regimen adherence in Indian women with polycystic ovarian syndrome. J Fam Med Prim Care. 2022;11(7):3687-92. doi: 10.4103/jfmpc.jfmpc_2360_21, PMID: 36387674
Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83(6):1976-87. doi: 10.1210/jcem.83.6.4990, PMID: 9626128
Falcetta P, Benelli E, Molinaro A, Di Cosmo C, Bagattini B, Del Ghianda S, et al. Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome. J Endocrinol Invest. 2021 Dec;44(12):2725-33. doi: 10.1007/s40618-021-01594-5, PMID: 34089497
Divya K, Mounisha B, Sowmya RV. Prevalence of polycystic ovarian syndrome among young women who attended tertiary care hospital, Visakhapatnam. Int J Curr Pharm Sci. 2024 Jul 15;16(4):75-8. doi: 10.22159/ijcpr.2024v16i4.5026
Pallavi K, Harshitha K. Study of prevalence of polycystic ovarian syndrome among adolescent and young adult students of Navodaya group of institutions. Int J Curr Pharm Sci. 2024 Jul 15;16(4):37-40. doi: 10.22159/ijcpr.2024v16i4.5003
Goh JE, Farrukh MJ, Keshavarzi F, Yap CS, Saleem Z, Salman M, et al. Assessment of prevalence, knowledge of polycystic ovary syndrome and health-related practices among women in Klang Valley: A cross-sectional survey. Front Endocrinol (Lausanne). 2022;13:985588. doi: 10.3389/fendo.2022.985588, PMID: 36105409
Alakananda A, Das BP, Goel I. A study on clinical profile of patients with polycystic ovarian syndrome. Int J Sci Res. 2017;6(10):1211-6.
Li X, Yang D, Pan P, Azziz R, Yang D, Cheng Y, et al. The degree of menstrual disturbance is associated with the severity of insulin resistance in PCOS. Front Endocrinol (Lausanne). 2022;13:873726. doi: 10.3389/fendo.2022.873726, PMID: 35769085
Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, et al. Androgen excess- polycystic ovary syndrome society: Position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018 May;109(5):888-99. doi: 10.1016/j.fertnstert.2018.01.038, PMID: 29778388
Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv. 2006 Nov;61(11):723-32. doi: 10.1097/01.ogx.0000243772.33357.84, PMID: 17044949
Guyatt G, Weaver B, Cronin L, Dooley JA, Azziz R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol. 2004 Dec;57(12):1279-87. doi: 10.1016/j.jclinepi.2003.10.018, PMID: 15617954
Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007 Aug;22(8):2279-86. doi: 10.1093/ humrep/dem108, PMID: 17537782
Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: Implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019 Sep 9;13:1179558119874042. doi: 10.1177/1179558119874042, PMID: 31523137.
Alur-Gupta S, Chemerinski A, Liu C, Lipson J, Allison K, Sammel MD, et al. Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertil Steril. 2019 Nov;112(5):930-8.e1. doi: 10.1016/j.fertnstert.2019.06.018, PMID: 31395311
Manohar R, Prasuna PL, Bajima KA, Reddy MH, Vardhan Reddy SN, Babu TS. Prevalence of depression and anxiety in polycystic ovarian syndrome women. Int J Pharm Pharm Sci. 2024 May 1;16(5):67-71. doi: 10.22159/ijpps.2024v16i5.50425
Franik G, Bizoń A, Włoch S, Kowalczyk K, Biernacka-Bartnik A, Madej P. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2018;22(14):4411-8. doi: 10.26355/eurrev_201807_15491, PMID: 30058676
Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes, and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2010 Jul-Aug;16(4):347-63. doi: 10.1093/humupd/dmq001, PMID: 20159883
Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol. 2005;153(6):853-60. doi: 10.1530/ eje.1.02024, PMID: 16322391
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome. Iran J Reprod Med. 2013 Oct;11(10):829-36. PMID: 24639704
Kolhe JV, Chhipa AS, Butani S, Chavda V, Patel SS. PCOS and depression: Common links and potential targets. Reprod Sci. 2022;29(11):3106-23. doi: 10.1007/s43032-021-00765-2, PMID: 34642910
Ligocka N, Chmaj-Wierzchowska K, Wszołek K, Wilczak M, Tomczyk K. Quality of life of women with polycystic ovary syndrome. Medicina (Kaunas). 2024;60(2):294. doi: 10.3390/medicina60020294, PMID: 38399581
Published
How to Cite
Issue
Section
Copyright (c) 2025 Sri Chandana Mavulati, Sujatha Dodoala
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
